Postoperative Pain Therapeutics Market to Reach Nearly US$ 17 Bn by 2027

1
Drug Class Opioids, NSAIDS, Local Anesthetics,
Tricyclic Antidepressants, Antiepileptic Drugs,
and Others Route of Administration Oral,
Intramuscular, Intravenous, and Others
Distribution Channel Hospital Pharmacies, Retail
Pharmacies, Online Pharmacies, and Others -
Forecast From 2019 - 2027
Postoperative Pain Therapeutics Market
2
Table of Content
Sr. No. Content
Chapter1 Preface
Chapter 2 Assumptions and Research Methodology
Chapter 3 Executive Summary Global Postoperative Pain Therapeutics Market
Chapter 4 Market Overview
Chapter 5 Market Outlook
Chapter 6 Global Postoperative Pain Therapeutics Market Analysis and Forecast, by Drug Class 
Chapter 7 Global Postoperative Pain Therapeutics Market Analysis and Forecast, by Mode of Administration 
Chapter 8 Global Postoperative Pain Therapeutics Market Analysis and Forecast, by Distribution Channel 
Chapter 9 Global Postoperative Pain Therapeutics Market Analysis and Forecast, by Region
Chapter 10 North America Postoperative Pain Therapeutics Market Analysis and Forecast
Chapter 11 Europe Postoperative Pain Therapeutics Market Analysis and Forecast
Chapter 12 Asia Pacific Postoperative Pain Therapeutics Market Analysis and Forecast
Chapter 13 Latin America Postoperative Pain Therapeutics Market Analysis and Forecast
Chapter 14 Middle East Africa Postoperative Pain Therapeutics Market Analysis and Forecast
Chapter 15  Company Profiles
3
Postoperative Pain Therapeutics Market Snapshot

• High incidence and severity of postoperative
  pain, introduction of promising drugs, increase
  in the number of surgical procedures, and high
  rate of adoption of pain management in developed
  as well as pharmerging countries are spurring the
  growth of the global postoperative pain
  therapeutics market.
• Surgical procedures are associated with chronic
  postoperative pain that persists for a long time,
  usually for three to six months. 
• Advancements in non-opioid alternatives and
  adjuncts have gained importance for controlling
  postoperative pain.
• Key Players - Mallinckrodt Pharmaceuticals,
  Pacira BioSciences, Inc., Trevena, Inc., Heron
  Therapeutics, Pfizer, Inc., Teva Pharmaceutical
  Industries Ltd., Novartis AG, Camarus, Eli Lilly
  Company, and Bayer AG.

4
(No Transcript)
5
Reports Highlights

• Gobal postoperative pain therapeutics market was
  valued at US 11,459.3 Mn in 2018, and is
  projected to expand at a CAGR of nearly 4.5 from
  2019 to 2027. 
• High Incidence and Severity of Postoperative
  Pain, Introduction of Promising Drugs, and High
  Adoption Rate of Pain Management in Developed as
  well as Pharmerging Countries to Drive the
  Postoperative Pain Therapeutics Market.
• Innovative medicines, increase in demand, better
  access, and improved treatment for pain have led
  to the dominance of postoperative pain
  therapeutics in pharmerging and developed
  markets. 
• Key Trend of Acquisition and Collaboration among
  Leading Players to Increase their Geographic
  Presence in the Postoperative Pain Therapeutics
  Market.

Request Sample
6
(No Transcript)